FI113473B - Menetelmä ergoliinijohdannaisten valmistamiseksi - Google Patents

Menetelmä ergoliinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI113473B
FI113473B FI934933A FI934933A FI113473B FI 113473 B FI113473 B FI 113473B FI 934933 A FI934933 A FI 934933A FI 934933 A FI934933 A FI 934933A FI 113473 B FI113473 B FI 113473B
Authority
FI
Finland
Prior art keywords
group
formula
process according
ergoline
alkyl
Prior art date
Application number
FI934933A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934933A0 (fi
FI934933A (fi
Inventor
Angelo Bedeschi
Franco Zarini
Walter Cabri
Ilaria Candiani
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of FI934933A0 publication Critical patent/FI934933A0/fi
Publication of FI934933A publication Critical patent/FI934933A/fi
Application granted granted Critical
Publication of FI113473B publication Critical patent/FI113473B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Control Of Electric Motors In General (AREA)
FI934933A 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi FI113473B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9205439 1992-03-12
GB929205439A GB9205439D0 (en) 1992-03-12 1992-03-12 Process for the synthesis of ergoline derivatives
EP9300360 1993-02-15
PCT/EP1993/000360 WO1993018034A1 (en) 1992-03-12 1993-02-15 Process for the preparation of ergoline derivatives

Publications (3)

Publication Number Publication Date
FI934933A0 FI934933A0 (fi) 1993-11-08
FI934933A FI934933A (fi) 1993-11-08
FI113473B true FI113473B (fi) 2004-04-30

Family

ID=10712024

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934933A FI113473B (fi) 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi

Country Status (25)

Country Link
US (1) US5382669A (de)
EP (1) EP0593692B1 (de)
JP (1) JP3339858B2 (de)
KR (1) KR100274102B1 (de)
CN (1) CN1038510C (de)
AT (1) ATE180783T1 (de)
AU (1) AU653099B2 (de)
CA (1) CA2106371C (de)
CZ (1) CZ281708B6 (de)
DE (1) DE69325138D1 (de)
FI (1) FI113473B (de)
GB (1) GB9205439D0 (de)
HU (1) HU210407B (de)
IL (1) IL104973A (de)
MX (1) MX9301297A (de)
MY (1) MY109152A (de)
NO (1) NO302754B1 (de)
NZ (1) NZ249115A (de)
PH (1) PH30138A (de)
RU (1) RU2118323C1 (de)
SK (1) SK279039B6 (de)
TW (1) TW215089B (de)
UA (1) UA26400C2 (de)
WO (1) WO1993018034A1 (de)
ZA (1) ZA931720B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6696568B2 (en) 2001-04-16 2004-02-24 Finetech Ltd. Process and intermediates for production of cabergoline and related compounds
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
HUP0400517A3 (en) * 2004-03-04 2006-05-29 Richter Gedeon Vegyeszet Process for producing cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
FR2877945A1 (fr) * 2004-11-18 2006-05-19 Archemis Sa Procede de la preparation de la cabergoline
EP1858894A1 (de) 2005-03-17 2007-11-28 Synthon Argentina S.A. Verbessertes verfahren zur herstellung von cabergolin
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1925616A1 (de) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Verfahren zur Herstellung kristalliner Formen des Cabergolins via stabile Solvate des Cabergolins
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
WO2014078857A1 (en) 2012-11-19 2014-05-22 Regents Of The University Of Minnesota Ergoline derivatives as dopamine receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2103603B (en) * 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives

Also Published As

Publication number Publication date
SK140193A3 (en) 1994-11-09
EP0593692B1 (de) 1999-06-02
HUT66712A (en) 1994-12-28
HU210407B (en) 1995-04-28
KR100274102B1 (ko) 2000-12-15
JP3339858B2 (ja) 2002-10-28
NO934077L (no) 1993-11-11
IL104973A (en) 1997-06-10
ZA931720B (en) 1993-11-01
CA2106371A1 (en) 1993-09-13
GB9205439D0 (en) 1992-04-22
MY109152A (en) 1996-12-31
TW215089B (de) 1993-10-21
NZ249115A (en) 1995-04-27
AU653099B2 (en) 1994-09-15
CZ281708B6 (cs) 1996-12-11
CZ271593A3 (en) 1994-04-13
WO1993018034A1 (en) 1993-09-16
MX9301297A (es) 1993-09-01
NO934077D0 (no) 1993-11-11
DE69325138D1 (de) 1999-07-08
AU3497493A (en) 1993-10-05
CN1076196A (zh) 1993-09-15
IL104973A0 (en) 1993-07-08
US5382669A (en) 1995-01-17
JPH06507648A (ja) 1994-09-01
RU2118323C1 (ru) 1998-08-27
EP0593692A1 (de) 1994-04-27
SK279039B6 (sk) 1998-05-06
NO302754B1 (no) 1998-04-20
PH30138A (en) 1997-01-21
FI934933A0 (fi) 1993-11-08
CN1038510C (zh) 1998-05-27
FI934933A (fi) 1993-11-08
CA2106371C (en) 2003-09-23
ATE180783T1 (de) 1999-06-15
UA26400C2 (uk) 1999-08-30

Similar Documents

Publication Publication Date Title
FI113473B (fi) Menetelmä ergoliinijohdannaisten valmistamiseksi
KR940004073B1 (ko) 라파마이신 전구체의 제조방법
GB2103603A (en) Ergoline derivatives
Esker et al. Multiple reaction channels of (N-Acyl-N-alkylcarbamoyl) oxyl radicals from N-acyl PTOC carbamates
KR870001064B1 (ko) 1,2,4-트리아졸-3-카르복스아미드류의 제조 방법
岡田至 et al. Synthesis and acaricidal activity of bicyclic pyrazole-3-carboxamide derivatives
IL27897A (en) Preparation of pyrazinoalguanides and pyrazinoamidoguanidines
Lange et al. Direct Pyridazine Ring Synthesis from β-Cyano Esters. A Facile Synthesis of the Derivatives of Tetrahydro-3, 6-pyridazinedione 3-Hydrazone
EP4345102A1 (de) Verbesserte synthese von otviciclib
IE911011A1 (en) NOVEL DERIVATIVES OF¹4H-PYRROLO[1,2-a]THIENO[2,3-f][1,4]DIAZEPINE THEIR PROCESS¹OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS¹CONTAINING THEM
JPH04270288A (ja) チエノ〔２，３−ｂ〕インドリジン誘導体
SU1214669A1 (ru) Способ получени 2-алкилроданинов
Paparin et al. Synthesis of 2, 5‐bis‐arylpyridines by [4+ 2] cycloaddition of 1, 4‐bis aryl‐2‐aza‐1, 3‐butadienes with electron‐poor dienophiles
Asensio et al. Synthesis of chiral β-disulfoxides and their racemization with strong bases
JPH0376313B2 (de)
TH13523A (th) กรรมวิธีในการเตรียมอนุพันธ์เออร์โกลีน
US3138633A (en) Synthesis of beta-cyanovinyl ammonium halides
JPH04117367A (ja) フルオロアルキル基含有ピリミジン誘導体の製造方法
Nozaki et al. Reduction of sulfoxides by thioformamizium salts
JPH04149192A (ja) フルオロアルキル基含有ウリジン誘導体の製造方法
Dunn et al. The reaction of some Halogenated Pyridine Thioethers and sulphones with carbon disulphide
JPS63303990A (ja) １−有機チオグリコシル化合物の製造法
JPH02108691A (ja) 縮合複素環化合物の製造法
JPS62283970A (ja) ２，３，５−三置換テトラヒドロフランの製造法
FR2590901A1 (fr) Procede de preparation de n-sulfonyl n-(phosphonomethyl-glycyl) amines utilisables comme herbicides

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.